Tumori Journal

Papers
(The H4-Index of Tumori Journal is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval56
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort43
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer32
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide31
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis16
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study13
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age11
Chemo-surgical approach in vulvar leiomyosarcoma: A case report10
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer10
Oral vinorelbine in young patients with desmoid-type fibromatosis10
0.10956597328186